<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9607835</journal-id>
<journal-id journal-id-type="pubmed-jr-id">20545</journal-id>
<journal-id journal-id-type="nlm-ta">Mol Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Molecular psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">1359-4184</issn>
<issn pub-type="epub">1476-5578</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29875475</article-id>
<article-id pub-id-type="pmc">6281782</article-id>
<article-id pub-id-type="doi">10.1038/s41380-018-0077-6</article-id>
<article-id pub-id-type="manuscript">NIHMS989415</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Translational studies support a role for serotonin 2B receptor (<italic>HTR2B</italic>) gene in aggression-related cannabis response</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Montalvo-Ortiz</surname>
<given-names>Janitza L.</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhou</surname>
<given-names>Hang</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>D’Andrea</surname>
<given-names>Ivana</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maroteaux</surname>
<given-names>Luc</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lori</surname>
<given-names>Adriana</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Smith</surname>
<given-names>Alicia</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ressler</surname>
<given-names>Kerry J.</given-names>
</name>
<degrees>M.D., Ph.D.</degrees>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nuñez</surname>
<given-names>Yaira Z.</given-names>
</name>
<degrees>B.A.</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Farrer</surname>
<given-names>Lindsay A.</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Hongyu</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A7">7</xref>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kranzler</surname>
<given-names>Henry R.</given-names>
</name>
<degrees>M.D.</degrees>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gelernter</surname>
<given-names>Joel</given-names>
</name>
<degrees>M.D.</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A9">9</xref>
<xref ref-type="aff" rid="A10">10</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Yale School of Medicine, Department of Psychiatry, New Haven, Connecticut, USA.</aff>
<aff id="A2"><label>2</label>INSERM UMR-S 839, F-75005, Paris, France; Sorbonne Universités, UPMC Univ Paris 6, F-75005, Paris; Institut du Fer à Moulin, F-75005, Paris.</aff>
<aff id="A3"><label>3</label>Emory University School of Medicine, Department of Psychiatry and Behavioral Sciences, Atlanta, Georgia, USA.</aff>
<aff id="A4"><label>4</label>Harvard Medical School and McLean Hospital, Department of Psychiatry, Belmont, Massachusets, USA.</aff>
<aff id="A5"><label>5</label>VA CT Healthcare Center, West Haven, Connecticut, USA.</aff>
<aff id="A6"><label>6</label>Boston University Schools of Medicine and Public Health, Departments of Medicine (Biomedical Genetics), Neurology, Ophthalmology, Epidemiology, and Biostatistics, Boston, Massachusets, USA.</aff>
<aff id="A7"><label>7</label>Yale School of Public Health, Department of Biostatistics, New Haven, Connecticut, USA.</aff>
<aff id="A8"><label>8</label>University of Pennsylvania Perelman School of Medicine, Department of Psychiatry, Center for Studies of Addiction and Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA.</aff>
<aff id="A9"><label>9</label>Yale School of Medicine, Department of Genetics, New Haven, Connecticut, USA.</aff>
<aff id="A10"><label>10</label>Yale School of Medicine, Department of Neuroscience, New Haven, Connecticut, USA.</aff>
<author-notes>
<corresp id="CR1"><label>*</label>Correspondence to: Joel Gelernter, Yale University School of Medicine, Department of Psychiatry, VA CT 116A2; 950 Campbell Avenue; West Haven, CT 06516; <email>joel.gelernter@yale.edu</email></corresp>
<fn fn-type="COI-statement" id="FN1">
<p id="P34">Conflict of interest statement</p>
<p id="P35">Although unrelated to the current study, HRK has been a consultant, advisory board member, or CME speaker for Indivior and Lundbeck. He is also a member of the American Society of Clinical Psychopharmacology's Alcohol Clinical Trials Initiative, which in the last three years was supported by Abbvie, Alkermes, Amygdala Neurosciences, Arbor, Ethypharm, Indivior, Lilly, Lundbeck, Otsuka, and Pfizer. No other authors declare possible conflicts.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>21</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>06</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>03</day>
<month>1</month>
<year>2019</year>
</pub-date>
<volume>23</volume>
<issue>12</issue>
<fpage>2277</fpage>
<lpage>2286</lpage>
<!--elocation-id from pubmed: 10.1038/s41380-018-0077-6-->
<abstract id="ABS1">
<p id="P1">Cannabis use is increasing in the United States, as are its adverse effects. We investigated the genetics of an adverse consequence of cannabis use: cannabis-related aggression (CRA) using a genome-wide association study (GWAS) design. Our GWAS sample included 3,269 African-Americans (AAs) and 2,546 European Americans (EAs). An additional 89 AA subjects from the Grady Trauma Project (GTP) were also examined using a proxy-phenotype replication approach. We identified genome-wide significant risk loci contributing to CRA in AAs at the serotonin receptor 2B receptor gene (<italic>HTR2B</italic>), and the lead SNP, <italic>HTR2B</italic>*rs17440378, showed nominal association to aggression in the GTP cohort of cannabis-exposed subjects. <italic>A priori</italic> evidence linked <italic>HTR2B</italic> to impulsivity/aggression but not to cannabis response. Human functional data regarding the <italic>HTR2B</italic> variant further supported our finding. Treating an <italic>Htr2b</italic><sup>−/−</sup> knockout mouse with THC resulted in increased aggressive behavior, whereas wild type mice following THC administration showed decreased aggression in the resident-intruder paradigm, demonstrating that <italic>HTR2B</italic> variation moderates the effects of cannabis on aggression. These concordant findings in mice and humans implicate <italic>HTR2B</italic> as a major locus associated with cannabis-induced aggression.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>